Regulatory Affairs.FDA · EMA · PMDA.
We prepare IND, NDA, BLA, MAA, and device submission packages for the United States, Europe, and Japan — from first-in-human through approval and post-market.
Every deliverable grounded in the best available evidence and highest methodological standards.
Commercial interests never shape our science. Independence is our non-negotiable standard.
Regulatory expertise for FDA, EMA, and PMDA across the full product lifecycle.
Systematic Reviews, LLC is a full-service medical communications and regulatory affairs consultancy built at the intersection of science, medicine, and strategy. Work is performed by medical doctors, regulatory scientists, and professional medical writers engaged on a per-project basis and matched to therapeutic area and scope. We operate across five specialized divisions — each designed to advance science, support regulatory success, and communicate medical knowledge with the accuracy it deserves.
Learn More About UsFive specialized divisions. One unified commitment to scientific excellence.
Feature articles, medical news, and product communications — distilling cutting-edge science for clinicians, patients, and industry with accuracy and depth.
Learn MoreIND, NDA, BLA, and device submissions for the FDA, EMA, and PMDA — strategic regulatory support across the full product lifecycle in the USA, Europe, and Japan.
Learn MoreManuscript development, publication strategy, CRO scientific content, and expert editing — getting the right science to the right journals and the right audiences.
Learn MoreACCME-compliant CME programs that close clinical practice gaps, advance medical knowledge, and meet the highest standards of educational independence.
Learn MoreRigorous, PRISMA-compliant systematic reviews conducted and published at no charge — the scientific backbone of everything we do. Authorship program now open.
Join Authorship ProgramPharmaceutical companies, biotechs, CROs, academic institutions, and individual researchers — we welcome all inquiries.
Get in TouchOur Systematic Reviews division is offered entirely free of charge as a public and scientific community service. No commercial interests. No participation fees. No exceptions. We keep this division completely independent because the best available evidence should be freely accessible to all — and because our credibility in every other division depends on demonstrating, not just claiming, that scientific integrity comes first.
Whether you need regulatory submission support, medical communications, scientific publications, CME development, or wish to join our free systematic review authorship program — we are ready to work with you.